Pharmacokinetics of depofoam gentamicin delivery system and effect on soft tissue infection

Leila S. Grayson, John F. Hansbrough, Ramon Zapata Sirvent, Taehee Kim, Sinil Kim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Infections of burn and soft tissue wounds are often difficult to treat with systemic antibiotics since drug delivery to the wound may be suboptimal and high doses may result in toxicity. Depofoam particles, a novel lipid-based drug delivery system, are composed of phospholipid membranes, enclosing multiple aqueous chambers into which pharmacologic agents can be encapsulated for local drug delivery. We encapsulated gentamicin (GENT) in DepoFoam particles with an average yield of 81% ± 8 SD for 10 preparations. Encapsulated GENT was incubated in human plasma with t1/2 of 21 days, demonstrating stability in vitro. In vivo pharmacokinetics were determined by injecting CF-1 mice subcutaneously (sc) with a single dose of 0.5 mg of free (nonencapsulated drug) or DepoFoam GENT. At intervals postinjection the sc tissue was excised and blood was obtained by inferior cava puncture and both were assayed for GENT levels. At 0.5, 2, 6, and 24 hr following drug administration there was a significant difference between GENT levels in the tissue achieved with the encapsulated drug and free drug with n = 3-4 at each time point for each group (P < 0.01). By 24 hr following administration of free drug there was minimal detectable GENT in the tissues, while therapeutic levels of GENT remained in tissue at 24 hr following DepoFoam GENT injection. Serum GENT peaked at 30 min for both the DepoFoam (5 μg/ml) and free drug (10 μg/ml) and was undetectable by 2 hr (n = 3 each group). Other mice received sc pretreatment on the dorsum with DepoFoam GENT (n = 18) or free GENT (n = 13) followed 2 days later with inoculation of 107Staphylococcus aureus in the site where the antibiotic had been injected previously. At 48 hr postinfection, colony-forming units (CFU) of S. aureus per gram of tissue were determined. Animals which had received DepoFoam GENT had a fourfold log10 reduction in CFU compared to animals which received free GENT, sterile water, and nondrug containing DepoFoam. DepoFoam drug delivery offers a promising method of providing sustained, high concentrations of antibiotic to local tissues while avoiding prolonged exposure to toxic systemic levels.

Original languageEnglish (US)
Pages (from-to)559-564
Number of pages6
JournalJournal of Surgical Research
Volume55
Issue number5
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Soft Tissue Infections
Gentamicins
Pharmacokinetics
Pharmaceutical Preparations
Anti-Bacterial Agents
Stem Cells
Poisons
Wounds and Injuries
Drug Delivery Systems
Punctures
Phospholipids

ASJC Scopus subject areas

  • Surgery

Cite this

Pharmacokinetics of depofoam gentamicin delivery system and effect on soft tissue infection. / Grayson, Leila S.; Hansbrough, John F.; Zapata Sirvent, Ramon; Kim, Taehee; Kim, Sinil.

In: Journal of Surgical Research, Vol. 55, No. 5, 01.01.1993, p. 559-564.

Research output: Contribution to journalArticle

Grayson, Leila S. ; Hansbrough, John F. ; Zapata Sirvent, Ramon ; Kim, Taehee ; Kim, Sinil. / Pharmacokinetics of depofoam gentamicin delivery system and effect on soft tissue infection. In: Journal of Surgical Research. 1993 ; Vol. 55, No. 5. pp. 559-564.
@article{62acab4116c64e648b3038220a0f9af2,
title = "Pharmacokinetics of depofoam gentamicin delivery system and effect on soft tissue infection",
abstract = "Infections of burn and soft tissue wounds are often difficult to treat with systemic antibiotics since drug delivery to the wound may be suboptimal and high doses may result in toxicity. Depofoam particles, a novel lipid-based drug delivery system, are composed of phospholipid membranes, enclosing multiple aqueous chambers into which pharmacologic agents can be encapsulated for local drug delivery. We encapsulated gentamicin (GENT) in DepoFoam particles with an average yield of 81{\%} ± 8 SD for 10 preparations. Encapsulated GENT was incubated in human plasma with t1/2 of 21 days, demonstrating stability in vitro. In vivo pharmacokinetics were determined by injecting CF-1 mice subcutaneously (sc) with a single dose of 0.5 mg of free (nonencapsulated drug) or DepoFoam GENT. At intervals postinjection the sc tissue was excised and blood was obtained by inferior cava puncture and both were assayed for GENT levels. At 0.5, 2, 6, and 24 hr following drug administration there was a significant difference between GENT levels in the tissue achieved with the encapsulated drug and free drug with n = 3-4 at each time point for each group (P < 0.01). By 24 hr following administration of free drug there was minimal detectable GENT in the tissues, while therapeutic levels of GENT remained in tissue at 24 hr following DepoFoam GENT injection. Serum GENT peaked at 30 min for both the DepoFoam (5 μg/ml) and free drug (10 μg/ml) and was undetectable by 2 hr (n = 3 each group). Other mice received sc pretreatment on the dorsum with DepoFoam GENT (n = 18) or free GENT (n = 13) followed 2 days later with inoculation of 107Staphylococcus aureus in the site where the antibiotic had been injected previously. At 48 hr postinfection, colony-forming units (CFU) of S. aureus per gram of tissue were determined. Animals which had received DepoFoam GENT had a fourfold log10 reduction in CFU compared to animals which received free GENT, sterile water, and nondrug containing DepoFoam. DepoFoam drug delivery offers a promising method of providing sustained, high concentrations of antibiotic to local tissues while avoiding prolonged exposure to toxic systemic levels.",
author = "Grayson, {Leila S.} and Hansbrough, {John F.} and {Zapata Sirvent}, Ramon and Taehee Kim and Sinil Kim",
year = "1993",
month = "1",
day = "1",
doi = "10.1006/jsre.1993.1184",
language = "English (US)",
volume = "55",
pages = "559--564",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Pharmacokinetics of depofoam gentamicin delivery system and effect on soft tissue infection

AU - Grayson, Leila S.

AU - Hansbrough, John F.

AU - Zapata Sirvent, Ramon

AU - Kim, Taehee

AU - Kim, Sinil

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Infections of burn and soft tissue wounds are often difficult to treat with systemic antibiotics since drug delivery to the wound may be suboptimal and high doses may result in toxicity. Depofoam particles, a novel lipid-based drug delivery system, are composed of phospholipid membranes, enclosing multiple aqueous chambers into which pharmacologic agents can be encapsulated for local drug delivery. We encapsulated gentamicin (GENT) in DepoFoam particles with an average yield of 81% ± 8 SD for 10 preparations. Encapsulated GENT was incubated in human plasma with t1/2 of 21 days, demonstrating stability in vitro. In vivo pharmacokinetics were determined by injecting CF-1 mice subcutaneously (sc) with a single dose of 0.5 mg of free (nonencapsulated drug) or DepoFoam GENT. At intervals postinjection the sc tissue was excised and blood was obtained by inferior cava puncture and both were assayed for GENT levels. At 0.5, 2, 6, and 24 hr following drug administration there was a significant difference between GENT levels in the tissue achieved with the encapsulated drug and free drug with n = 3-4 at each time point for each group (P < 0.01). By 24 hr following administration of free drug there was minimal detectable GENT in the tissues, while therapeutic levels of GENT remained in tissue at 24 hr following DepoFoam GENT injection. Serum GENT peaked at 30 min for both the DepoFoam (5 μg/ml) and free drug (10 μg/ml) and was undetectable by 2 hr (n = 3 each group). Other mice received sc pretreatment on the dorsum with DepoFoam GENT (n = 18) or free GENT (n = 13) followed 2 days later with inoculation of 107Staphylococcus aureus in the site where the antibiotic had been injected previously. At 48 hr postinfection, colony-forming units (CFU) of S. aureus per gram of tissue were determined. Animals which had received DepoFoam GENT had a fourfold log10 reduction in CFU compared to animals which received free GENT, sterile water, and nondrug containing DepoFoam. DepoFoam drug delivery offers a promising method of providing sustained, high concentrations of antibiotic to local tissues while avoiding prolonged exposure to toxic systemic levels.

AB - Infections of burn and soft tissue wounds are often difficult to treat with systemic antibiotics since drug delivery to the wound may be suboptimal and high doses may result in toxicity. Depofoam particles, a novel lipid-based drug delivery system, are composed of phospholipid membranes, enclosing multiple aqueous chambers into which pharmacologic agents can be encapsulated for local drug delivery. We encapsulated gentamicin (GENT) in DepoFoam particles with an average yield of 81% ± 8 SD for 10 preparations. Encapsulated GENT was incubated in human plasma with t1/2 of 21 days, demonstrating stability in vitro. In vivo pharmacokinetics were determined by injecting CF-1 mice subcutaneously (sc) with a single dose of 0.5 mg of free (nonencapsulated drug) or DepoFoam GENT. At intervals postinjection the sc tissue was excised and blood was obtained by inferior cava puncture and both were assayed for GENT levels. At 0.5, 2, 6, and 24 hr following drug administration there was a significant difference between GENT levels in the tissue achieved with the encapsulated drug and free drug with n = 3-4 at each time point for each group (P < 0.01). By 24 hr following administration of free drug there was minimal detectable GENT in the tissues, while therapeutic levels of GENT remained in tissue at 24 hr following DepoFoam GENT injection. Serum GENT peaked at 30 min for both the DepoFoam (5 μg/ml) and free drug (10 μg/ml) and was undetectable by 2 hr (n = 3 each group). Other mice received sc pretreatment on the dorsum with DepoFoam GENT (n = 18) or free GENT (n = 13) followed 2 days later with inoculation of 107Staphylococcus aureus in the site where the antibiotic had been injected previously. At 48 hr postinfection, colony-forming units (CFU) of S. aureus per gram of tissue were determined. Animals which had received DepoFoam GENT had a fourfold log10 reduction in CFU compared to animals which received free GENT, sterile water, and nondrug containing DepoFoam. DepoFoam drug delivery offers a promising method of providing sustained, high concentrations of antibiotic to local tissues while avoiding prolonged exposure to toxic systemic levels.

UR - http://www.scopus.com/inward/record.url?scp=0027517578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027517578&partnerID=8YFLogxK

U2 - 10.1006/jsre.1993.1184

DO - 10.1006/jsre.1993.1184

M3 - Article

C2 - 8231176

AN - SCOPUS:0027517578

VL - 55

SP - 559

EP - 564

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 5

ER -